Covered recipient · General Payments record
JOHN BRIAN JACQUEMIN
Allopathic & Osteopathic Physicians Orthopaedic Surgery
General Payments · PY2018–2023
$5,328.30
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2023 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,214.71 | 8 |
| Food and Beverage | $755.67 | 10 |
By paying entity
PY2023 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Medtronic, Inc. | $1,118.85 | 9 |
| NuVasive, Inc. | $478.86 | 6 |
| Relievant Medsystems, Inc. | $158.45 | 1 |
| Kuros Biosciences USA, Inc | $109.81 | 1 |
| Abbott Laboratories | $104.41 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2023 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $104.41 | 09/02/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019611289 | CMS |
| Kuros Biosciences USA, Inc | $109.81 | 07/12/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1060665699 | CMS |
| Medtronic, Inc. | $492.49 | 09/08/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019498595 | CMS |
| Medtronic, Inc. | $32.31 | 09/08/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019498603 | CMS |
| Medtronic, Inc. | $113.18 | 09/22/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1007557027 | CMS |
| Medtronic, Inc. | $219.00 | 09/22/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019498625 | CMS |
| Medtronic, Inc. | $40.36 | 09/22/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1019498633 | CMS |
| Medtronic, Inc. | $50.27 | 09/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1007557035 | CMS |
| Medtronic, Inc. | $52.88 | 09/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019498609 | CMS |
| Medtronic, Inc. | $76.38 | 09/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019498613 | CMS |
| Medtronic, Inc. | $41.98 | 09/23/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1019498619 | CMS |
| NuVasive, Inc. | $25.00 | 09/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1049551307 | CMS |
| NuVasive, Inc. | $214.03 | 09/18/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1049551313 | CMS |
| NuVasive, Inc. | $35.36 | 10/18/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049551553 | CMS |
| NuVasive, Inc. | $12.95 | 10/20/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1049551541 | CMS |
| NuVasive, Inc. | $101.28 | 10/24/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1049551527 | CMS |
| NuVasive, Inc. | $90.24 | 10/24/2023 | Travel and Lodging | Undisputed | 01/23/2026 | 1049551533 | CMS |
| Relievant Medsystems, Inc. | $158.45 | 08/30/2023 | Food and Beverage | Undisputed | 01/23/2026 | 1023516207 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023
- Generated from
- OP_DTL_GNRL_PGYR2023_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.